We Are the
RI-MUHC HYPERTENSION AND VASCULAR DISEASES NETWORK
From the stethoscope to the microscope to the telescope. We aim to make a difference in the lives of all those living with hypertension.
About the Project
Hypertension continues to be the leading cause of morbidity and mortality globally, with sub-optimal control affecting 40-50% of individuals over the age of 40, which equates to over 1 billion people worldwide. Although Canada has historically excelled in hypertension care, it is currently experiencing its lowest rates of awareness, treatment, and control, particularly among females, resulting in an increased prevalence of hypertension-related complications such as myocardial infarction, heart or kidney failure, stroke, and cognitive disorders. Despite the availability of more than 150 antihypertensive medications, the incidence of uncontrolled hypertension is on the rise. This challenge is partly due to poor adherence and the prevalent ‘one size fits all’ approach in hypertension management, which often overlooks the diverse and complex nature of the patient population. A precision medicine approach is essential for effective hypertension management, as it considers the unique factors influencing each individual.
This Research Network is dedicated to identify individualized determinants and phenotypes of hypertension, ensuring that tailored treatment options will soon be available for all.
The Hard Truth
1.28 B
live with hypertension around the globe
46%
of adults with hypertension are not aware of their condition
<42%
of patients receive proper treatment